IDDI's Added Value:
- Experience in Oncology - Ophthalmology - Infectious diseases - Cardiovascular diseases.
- Expertise in methodology and specific study designs and analyses.
- Efficient web systems (ID-net™, ID-supply™, ID-code™, TrialControl™).
- Scientific publications and presentations (350+ publications and 400+ presentations).
- Dedicated team of talented professionals with extensive scientific depth.
- Trial results that are scientifically accurate, validated and reproducible.
- Stability and independent status, 20 years in the clinical trials business.
- Regulatory experience with involvement in 14 approvals.
- Worldwide reputation and scientific visibility.
Success Stories demonstrate how the methodology and web systems of IDDI are key in the conduct of the clinical trials.
300 trials (Phase I-IV) over the last 5 years
>> FREE LIVE WEBINAR
FRIDAY SEPTEMBER 3, 2010
DEVELOPMENT AND VALIDATION OF CLINICALLY USEFUL GENE SIGNATURES
Join Marc Buyse of IDDI and Stefan Michiels of Institut Bordet.
Friday September 3, 2010
04:00 PM CET - 10:00 AM EST - 7:00 AM PST
Past Webinar :
- June 22: Webinar on Statistical Validation on Biomarkers.
We were particularly happy and proud to welcome more than 250 registrants!